The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders ...

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

Pfizer ($PFE) became a household name during the pandemic, and its stock rose along with its fame. However, three years later ...

Roche's diversified portfolio and ongoing GLP-1 developments offer decent upside with limited downside. Read more about RHHBY ...

On the heels of Terns’ positive Phase I results that analysts compared with Lilly’s and Pfizer’s weight loss pills in ...